Product Information
MECLIZINE 25 MG TABLET is a generic product labeled by Apnar Pharma LP, priced at $0.1281 per EA under NDC 24689014601. Its NADAC has been published 82 times since Mar 12, 2025.
Strength
25 mg/1
Manufacturer
Apnar Pharma LPNDC
24689014601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M009On Market Since
11/21/2022
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 25 MG TABLET has been published 82 times since Mar 12, 2025, and over the history we have for it it has risen 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1281 per EA |
|---|---|
| All-time high | $0.1344 (Jul 15, 2026) |
| All-time low | $0.1177 (Apr 23, 2025) |
| 52-week high | $0.1344 |
| 52-week low | $0.1252 |
| Median price | $0.1288 |
| Average price | $0.1283 |
| Largest weekly change | +9.7% (Jun 18, 2025) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apnar Pharma LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Meclizine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiemetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MECLIZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 25 MG TABLET, manufactured by Apnar Pharma LP, is $0.1281 per EA (NDC 24689014601), effective Sep 30, 2026.
How has the price of MECLIZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 25 MG TABLET has risen 2.1%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for MECLIZINE 25 MG TABLET?
Since Mar 12, 2025, the NADAC for MECLIZINE 25 MG TABLET has ranged from a low of $0.1177 (Apr 23, 2025) to a high of $0.1344 (Jul 15, 2026), with a median of $0.1288 per EA.
Are there cheaper alternatives to MECLIZINE 25 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MECLIZINE 25 MG TABLET CHEW, is $0.0333 per EA — about 74% below MECLIZINE 25 MG TABLET.
Who manufactures MECLIZINE 25 MG TABLET?
MECLIZINE 25 MG TABLET (NDC 24689014601) is labeled by Apnar Pharma LP, and CMS classifies it as a generic product.